A Single-Blind, Randomized, Placebo-Controlled, Safety, Tolerability, and Efficacy Trial of a Novel Botanical Drug Product, Containing East Indian Sandalwood Oil (EISO) For The Treatment of Atopic Dermatitis
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 14 Aug 2017
At a glance
- Drugs Santalum album (Primary)
- Indications Atopic dermatitis
- Focus Adverse reactions
- Sponsors Santalis Pharmaceuticals
- 08 Aug 2017 Planned End Date changed from 1 Oct 2017 to 1 Feb 2018.
- 08 Aug 2017 Status changed from recruiting to active, no longer recruiting.
- 24 Apr 2017 Planned primary completion date changed from 1 Oct 2017 to 1 Sep 2017.